Crystal Violet Staining: A Technique to Visualize Drug-Resistant Cancer Cells Using Colony Formation Assays

Abstract

Source: Mohr, L. et al., Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel. J. Vis. Exp. (2017)

In this video, we demonstrate a cell viability assay using a crystal violet staining procedure for chemotherapeutic drug-resistant cancer cells.

Protocol

1. Functional Characterization of Acquired Docetaxel Resistance by Colony Formation Assay

NOTE: In this protocol, chemoresistance has been evaluated using colony formation assays. Alternative methods used to evaluate cell viability (i.e., MTS assays) can be used based on investigators' preferences.

1. Plate 2,000 cells (DU145 or 22Rv1, both parental and Docetaxel-resistant) per well in 6-well plates, using 2 mL of media per well.
2. After 24 h, add increasing concentrations of Docetaxel (parental cells: 0.25, 0.5, 1, 2.5 and 5 nM; DR cells: 50, 125, 250, 500 and 1,000 nM) for both D....

Results

Figure 1: Functional and phenotypic characterization of the Docetaxel-resistant cell models. Representative colony formation assays of parental and Docetaxel-resistant cells treated with the indicated Docetaxel concentrations for 72 h. Percentage of colonies for every treatment concentratio.......

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
DU145 cells 	ATCC 	HTB-81
22Rv1 cells 	ATCC 	CRL-2505
Docetaxel 	Selleck Chemicals 	S1148 	in DMSO (10mM)
6-well tissue culture plates 	Falcon 	353046
RPMI 1640 Medium 	Gibco 	11875093	Supplemented with 10% FBS and 1% Penicilin/Streptomycin
Foundation B Fetal Bovine Serum 	Gemini 	900208
1X Phosphate-Buffered Saline (PBS) 	Corning 	21-040-CM
Crystal Violet 	Sigma-Aldrich 	C0775
10% Formalin Solution 	Sigma-Aldrich 	HT501128